MASS (908 Devices Inc.) Stock Financials & Earnings

MASS908 Devices Inc.

Mkt Cap$233M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$56M

Net Income (TTM)$19M

EPS (TTM)$0.55

Free Cash Flow (TTM)-$25M

Gross Margin50.6%

Op. Margin-70.1%

Net Margin34.7%

FCF Margin-43.9%

P/S Ratio (TTM)4.1x

P/E Ratio (TTM)11.9x

YoY Rev Growth+7.6%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$9M	$4M	-$13M
Q2 23	$12M	$6M	-$11M
Q3 23	$14M	$8M	-$9M
Q4 23	$14M	$7M	-$10M
Q1 24	$7M	$4M	-$8M
Q2 24	$11M	$6M	-$9M
Q3 24	$15M	$8M	-$24M
Q4 24	$19M	$9M	-$20M
Q1 25	$12M	$6M	-$11M
Q2 25	$13M	$6M	-$15M
Q3 25	$14M	$7M	-$16M
Q4 25	$17M	$9M	$3M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Quarter	Consumables and service	Contract	Product	Device Sales	Recurring
Q1 25	$3M	$63K	$9M	—	—
Q2 25	—	$20K	—	$8M	$5M
Q3 25	—	$54K	—	$9M	$5M

Revenue by Geography

Quarter	Americas other	Asia Pacific	Europe, Middle East and Africa	United States
Q1 23	$430K	$576K	$2M	$6M
Q2 23	$62K	$221K	$4M	$8M
Q3 23	$30K	$394K	$1M	$12M
Q1 25	$130K	$181K	$4M	$7M
Q2 25	$68K	$671K	$1M	$11M
Q3 25	$443K	$793K	$2M	$11M
Q4 25	$884K	$1M	$3M	$12M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$161M	$0	$161M
Q2 23	$133M	$20M	$153M
Q3 23	$118M	$30M	$148M
Q4 23	$121M	$25M	$146M
Q1 24	$105M	$30M	$134M
Q2 24	$47M	$31M	$77M
Q3 24	$45M	$27M	$72M
Q4 24	$44M	$26M	$70M
Q1 25	$79M	$45M	$124M
Q2 25	$62M	$57M	$119M
Q3 25	$63M	$49M	$112M
Q4 25	$113M	$0	$113M

Shares Outstanding

Revenue Per Employee

Revenue / Employee